Published 2 years ago

Moderna CEO says data for Omicron-specific shot likely available in March

Summary by Ground News

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks. The company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday. Many countries are already offering a third dose of a COVID-19 vaccine to their citizens.

0 Articles

All

Left

Center

Right

Times of India

Moderna CEO says data for Omicron-specific shot likely available in March

"The vaccine is being finished, it should be in the clinic in coming weeks. We are hoping in the March timeframe to be able to have data to share with regulators to figure out next steps," Bancel said at the World Economic Forum's virtual Davos Agenda conference.

2 years ago·India

Read Full Article

CTV News

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said on Monday.

2 years ago·Canada

Read Full Article

Reuters

Moderna CEO says data for Omicron-specific shot likely available in March

2 years ago·United Kingdom

Read Full Article

Financial Post

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna Inc’s vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be…

2 years ago·Canada

Read Full Article

India Today

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna is also developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot.

2 years ago·India

Read Full Article

Live Mint

Moderna CEO says data for Omicron-specific shot likely available in March

Moderna's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share data with regulators around March, CEO Stephane Bancel said

2 years ago·New Delhi, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.